Vasogen files $100 million shelf

New York, Dec 21 - Vasogen Inc. registered to sell up to $100 million of stock, debt securities and warrants in an F-10 shelf filing with the Securities and Exchange Commission.

Securities may be sold as convertibles or in combination as units.

Vasogen, a Mississauga, Ont., company working on technologies to treat the chronic inflammation underlying cardiovascular and neurological disease, will use proceeds for general corporate purposes unless specified otherwise at the time of sale.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.